WuXi AppTec Co Ltd (603259)

Currency in CNY
95.50
+0.30(+0.32%)
Delayed Data·
603259 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
95.2196.00
52 wk Range
48.48115.79
Key Statistics
Bid/Ask
95.52 / 95.54
Prev. Close
95.2
Open
95.21
Day's Range
95.21-96
52 wk Range
48.48-115.79
Volume
1.94M
Average Volume (3m)
39.73M
1-Year Change
72.5795%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603259 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
129.23
Upside
+35.32%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years

WuXi AppTec Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

WuXi AppTec Company Profile

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.

Employees
39414
Market
China

WuXi AppTec Co Ltd Earnings Call Summary for Q3/2025

  • WuXi AppTec beats Q3 2025 expectations with EPS of $1.24 and revenue of $12.06B, stock rises 3.36% to $103.81
  • Revenue up 22.5% YoY to RMB 32.86B for Q1-Q3 2025, driven by small molecule drug discovery and 121.1% growth in TIDES business
  • Full-year revenue guidance raised to RMB 43.5-44.0B, with 17-18% growth expected from continuing operations
  • Operating cash flow improved 35% YoY to RMB 10.87B; company projects free cash flow of RMB 8.0-8.5B for the year
  • Executives emphasize focus on meeting customer demands and maintaining high standards amid potential regulatory challenges
Last Updated: 27/10/2025, 02:24
Read Full Transcript

Compare 603259 to Peers and Sector

Metrics to compare
603259
Peers
Sector
Relationship
P/E Ratio
17.4x29.7x−0.6x
PEG Ratio
0.330.970.00
Price/Book
4.0x2.7x2.6x
Price / LTM Sales
6.5x3.4x3.4x
Upside (Analyst Target)
36.7%21.9%44.9%
Fair Value Upside
Unlock17.5%6.3%Unlock

Analyst Ratings

23 Buy
2 Hold
0 Sell
Ratings:
25 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 129.23
(+35.32% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
CLSA
Buy130.30+36.87%128.00Maintain07/01/2026
HSBC
Buy137.00+43.91%-Maintain23/12/2025
Nomura/Instinet
Buy120.85+26.94%118.83Maintain28/11/2025
Citi
Buy130.00+36.55%119.00Maintain29/10/2025
JPMorgan
Buy142.00+49.16%138.00Maintain29/10/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.05%
Dividend Yield
1.77%
Industry Median 0.80%
Annualised payout
1.68
Paid annually
5-Years Growth
+46.02%
Growth Streak

Earnings

Latest Release
Oct 31, 2025
EPS / Forecast
1.24 / 1.04
Revenue / Forecast
12.06B / 11.52B
EPS Revisions
Last 90 days

People Also Watch

59.60
002230
0.00%
22.70
300059
0.00%
22.36
603993
-8.10%
87.97
600309
0.00%
24.17
600585
-1.43%

FAQ

What Is the WuXi AppTec (603259) Share Price Today?

The live WuXi AppTec share price today is 95.50

What Stock Exchange Does WuXi AppTec (603259) Trade On?

WuXi AppTec is listed and trades on the Shanghai Stock Exchange.

What Is the Ticker (Stock Symbol) for WuXi AppTec?

The stock symbol (also called a 'ticker') for WuXi AppTec is "603259."

Does WuXi AppTec Pay Dividends? What’s The Current 603259 Dividend Yield?

Yes, 603259 Pays Dividends to its Shareholders. The current WuXi AppTec dividend yield is 1.77%.

What Is the Current WuXi AppTec Market Cap?

As of today, WuXi AppTec market capitalisation is 282.18B.

What Is WuXi AppTec's (603259) Earnings Per Share (TTM)?

The WuXi AppTec EPS is currently 5.05 (Trailing Twelve Months).

When Is the Next WuXi AppTec Earnings Date?

WuXi AppTec's next earnings report will be released on 24 Mar 2026.

Is 603259 a Buy or Sell From a Technical Analyst Perspective?

Based on today's WuXi AppTec moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has WuXi AppTec Stock Split?

WuXi AppTec has split 3 times. (See the 603259 stock split history page for full effective split date and price information.)

How Many Employees Does WuXi AppTec Have?

WuXi AppTec has 39414 employees.

What is the current trading status of WuXi AppTec (603259)?

As of 02 Feb 2026, WuXi AppTec (603259) is trading at a price of 95.50, with a previous close of 95.20. The stock has fluctuated within a day range of 95.21 to 96.00, while its 52-week range spans from 48.48 to 115.79.

What Is WuXi AppTec (603259) Price Target According to Analysts?

The average 12-month price target for WuXi AppTec is CNY129.23, with a high estimate of CNY145.5 and a low estimate of CNY93. 23 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +35.32% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.